JSDA

JONES SODA CO.
3 filings tracked
consumer staplesnon alcoholic beveragesMICRO (<$300M)

Signal Magnitude Chart

BULLISH | 80% | 3/31/2026 | margin expansionBULLISH | 70% | 3/31/2026 | divestitureBEARISH | 60% | 3/31/2026 | debt restructureBEARISH | 70% | 3/31/2026 | regulatory actionBULLISH | 90% | 5/14/2026 | earnings beatBEARISH | 40% | 5/14/2026 | margin compressionBULLISH | 60% | 5/14/2026 | capital raiseNEUTRAL | 50% | 5/14/2026 | debt restructureBULLISH | 90% | 5/14/2026 | earnings beatBEARISH | 40% | 5/14/2026 | margin compressionBULLISH | 60% | 5/14/2026 | capital raiseNEUTRAL | 50% | 5/14/2026 | debt restructureMar 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

bullishMay 14

Achieved positive net income of $115k compared to a significant loss in the prior year.

earnings beat
90%
bearishMay 14

Gross margin declined to 31.3% from 32.9% due to a shift toward lower-margin club channel products.

margin compression
40%
bullishMay 14

Announced a $2.5 million brokered private placement to bolster liquidity.

capital raise
60%
neutralMay 14

Monetized cannabis subsidiary note for $1.4 million to improve immediate cash position.

debt restructure
50%
bullishMay 14

Achieved positive net income of $115k compared to a significant loss in the prior year.

earnings beat
90%
bearishMay 14

Gross margin declined to 31.3% from 32.9% due to a shift toward lower-margin club channel products.

margin compression
40%
bullishMay 14

Announced a $2.5 million brokered private placement to bolster liquidity.

capital raise
60%
neutralMay 14

Monetized cannabis subsidiary note for $1.4 million to improve immediate cash position.

debt restructure
50%
bullishMar 31

Gross profit increased 84.8% due to channel optimization and lower trade spend.

margin expansion
80%
bullishMar 31

Sold cannabis business to reduce regulatory risk and generate a $3.9 million gain.

divestiture
70%
bearishMar 31

Reliance on a $10M credit facility with a high 13.75% interest rate.

debt restructure
60%
bearishMar 31

New federal THC caps threaten the viability of the HD9 hemp-derived product line.

regulatory action
70%

Filing History

10-QMay 14, 2026

The Q1 2026 filing presents a classic tug-of-war between top-line momentum and balance-sheet fragility. On one hand, the massive revenue jump and the shift to positive net income provide a compelling narrative of a successful pivot away from the regulatory volatility of the cannabis-derived beverage market. The company's ability to penetrate the club channel suggests a viable path to scale that could eventually offset its high cost of capital. However, the synthesis of the data suggests that Jones Soda is currently running a high-stakes race against its own debt. The transition to a 'multi-brand beverage company' is underway, but the reliance on high-interest loans and the lack of positive operating cash flow mean there is very little room for error. Investors must weigh the genuine excitement of the 'Fallout' growth against the reality of a company that is still fundamentally undercapitalized and vulnerable to any contraction in consumer demand.

10-KMar 31, 2026

The 10-K paints a picture of a company at a crossroads, balancing impressive growth metrics against a fragile balance sheet. On one hand, the surge in revenue and the expansion of gross margins suggest that management's new focus on channel optimization and IP-driven marketing is working. The reduction in operating losses and the strategic divestiture of the cannabis business indicate a leaner, more focused organization. However, the underlying financial instability cannot be ignored. The reliance on high-interest debt and the volatility of the hemp-derived product market create a high-risk profile. Investors are essentially betting on whether the current growth trajectory and brand revitalization can outpace the company's burn rate and regulatory headwinds before the next liquidity crunch occurs.